πŸ‡ΊπŸ‡Έ

US SEC Filing Intelligence

Β· daily

US Executive Officer Management Changes SEC β€” April 13, 2026

Across 23 SEC filings on USA executive and director changes dated April 13, 2026, the overriding theme is leadership optimization for growth, with 16 positive appointments/retainments (70%) outpacing 7 departures/resignations, including high-materiality CEO shifts at Conagra Brands (new CEO June 1) and TVA (separation). No explicit period-over-period financial declines reported in any filing; instead, stability is inferred from retention incentives like ProFrac's 287k PSUs to CEO/Exec Chair and Vistagen's options to all employees, contrasting with sector peers facing talent wars. Forward-looking data highlights catalysts such as ALX Oncology's evorpacept milestones in 12-18 months, Commvault's reaffirmed FY2026 guidance, and NET Power's financing expertise for 2.4GW portfolio. Insider activity via equity grants (e.g., CG Oncology $4M options/$1M PSUs to new CFO) signals management conviction, with no sales or pledges noted. Biotech/pharma dominates (9/23 filings) with net positive hires amid clinical pushes, while CFO turnover (8 companies) suggests finance-led transformations. Capital allocation tilts to LTIPs over dividends/buybacks, prioritizing retention; portfolio implication: overweight firms with smooth transitions for alpha in Q2-Q3 2026.

23 high priority 23 total filings
Β· daily

US Corporate Board Director Changes SEC Filings β€” April 13, 2026

Across 23 8-K filings from April 13, 2026, focused on USA boardroom changes, a net positive trend emerges with 14 positive sentiment events (board expansions, experienced hires) outpacing 3 negative (sudden resignations) and 6 neutral, signaling proactive leadership refreshes amid 2026 economic pressures. CFO turnover dominates with 9 changes/appointments (e.g., Net Power, AdvanSix, CG Oncology, Commvault, AeroVironment), often with interim bridges and retention incentives like $420K salaries + RSUs, reflecting stabilization efforts. Biotech/pharma sector leads with 7 filings (e.g., Solana CMO exit, ALX CDOO hire for 12-18 month catalysts), while consumer/food sees high-materiality CEO shifts (Conagra 10/10). No broad period-over-period financial declines reported; instead, equity plan expansions (Xenon +30.6% shares) and reaffirmed guidance (Commvault FY2026) indicate capital allocation toward talent retention over buybacks/dividends. Portfolio implication: overweight firms with growth-aligned hires (e.g., Webtoon restructuring for 160M MAUs); monitor CEO voids like TVA for succession risks. Overall, 70% of changes expand expertise in transformation/AI/power markets, positioning for outperformance vs. stagnant peers.

23 high priority 23 total filings
Β· daily

US Merger & Acquisition SEC Filings β€” April 13, 2026

A remarkable surge in USA M&A and takeover activity on April 13, 2026, with 11 filings dominated by SPAC business combinations and asset acquisitions in high-growth AI sectors including fintech lending, healthcare analytics, defense detection, and video intelligence. Five positive-sentiment deals (IVCA-Blue Finance $220M, Sizzle-Trasteel $800M, CCTC AI IP, PHGE-DFSL defense, VWAV-xClibre $60M IP) highlight bullish M&A momentum, with no reported YoY/QoQ financial declines but forward-looking earnouts and milestones signaling growth potential. Neutral filings reflect SPAC lifecycle pressures like 3 extensions (Future Vision II $191K note, Inception $12K deposit) and 1 adjournment (Ribbon to Sep 2026), indicating sponsor commitment amid deadline risks but no insider selling or capital cuts. High materiality averages 7/10, with portfolio-level pattern of AI-themed takeovers (4/11 filings) vs routine SPAC housekeeping (4/11). Market implications: Elevated pre-close volatility for SPACs, alpha in AI M&A targets; no sector-wide margin compression or ratio deteriorations noted. Catalyst calendar dense with shareholder votes, F-4 filings, and H2 2026 POCs.

11 high priority 11 total filings
Β· monthly

US Pre-Market SEC Filings Roundup β€” April 13, 2026

Overnight SEC filings reveal a surge in biotech catalysts with multiple positive trial readouts (IDEAYA, Spyre, Allogene) signaling potential NDAs and Phase 3 advancements in 2026-2028, alongside robust M&A activity including Somnigroup's $2.5B all-stock acquisition of Leggett & Platt (expected YE2026 close) and Clear Channel's $2.43/share merger. Period-over-period trends show strong revenue acceleration in select small caps and biotechs (Alamar Biosciences +195% YoY to $74.2M, EACO +17.7% QoQ to $117.8M, AITX +26% FY2026 prelim to $7.75M) but widespread margin compression (Digital Ally 23% to 10%, ALT5 48% to 41%) and persistent net losses amid SG&A spikes. Capital allocation leans shareholder-friendly with American States Water's 8.3% dividend hike (71st year) and News Corp's $1B buyback, while IPO filings (Alamar, Kailera, National Healthcare) and ATM offerings signal capital raises amid mixed sentiment. Portfolio-level patterns highlight biotech outperformance vs. small-cap distress (delisting risks, contract losses), with 13F disclosures showing institutional accumulation in tech giants (Apple, Broadcom). Key implications: Biotech sector rotation opportunity pre-market open, monitor M&A regulatory hurdles, and favor revenue growers like EACO over margin squeezes.

25 high priority 20 medium 45 total filings
Β· daily

New Federal Contractors β€” April 12, 2026

Two new civilian federal contracts totaling $1,954,256,236 in obligations were awarded, with 0/2 defense-related and a split fully weighted toward civilian agencies including Department of Commerce and Department of Education. The dominant theme is large-scale civilian procurement, led by L3HARRIS TECHNOLOGIES, INC.'s $1.83B award from Department of Commerce, a bullish signal at 7/10 strength and 8/10 materiality despite limited details. MISSOURI HIGHER EDUCATION LOAN AUTHORITY received a neutral $128M obligation (options to $295M) from Department of Education for student loan servicing. Highest-conviction signal is bullish growth for L3Harris in civilian tech-adjacent work. Key watch item is outlay progress from $0 on the MOHELA contract and potential option exercises to $295M.

2 total filings
Β· daily

Significant Contract Modifications ($10M+) β€” April 12, 2026

Two significant civilian contract modifications totaling $1,954,256,236 were processed from April 12 to April 12, 2026, with 0/2 defense-related, dominated by the Department of Commerce's $1.83B award to L3Harris Technologies, Inc. The highest-conviction signal is bullish on L3Harris (materiality 8/10, strength 7/10), providing durable revenue visibility in a civilian context despite its defense heritage. A secondary neutral signal emerges from the Department of Education's $128M obligation to nonprofit Missouri Higher Education Loan Authority for student loan servicing, with potential expansion to $295M via options. No cross-contract patterns in recipients or agencies. Key watch item: outlay progress on Missouri Higher Education Loan Authority contract, currently at $0 despite obligation.

2 total filings
Β· daily

Contract Deobligations Alert β€” April 12, 2026

Contract deobligations alert for April 12, 2026, aggregates $1,954,256,236 in total obligations across two actions, entirely civilian with 0/2 defense-related and average signal strength 5.5/10. The dominant event is Department of Commerce's $1,826,088,581 deobligation involving L3Harris Technologies, Inc. (2009 award), the highest-conviction bullish signal (strength 7/10, materiality 8/10). Department of Education's $128,167,655 deobligation to Missouri Higher Education Loan Authority (March 31, 2026 award) carries a neutral signal (strength 4/10, materiality 4/10) in student loan servicing. Civilian agencies (Commerce, Education) drive the theme of obligation adjustments. Key watch item: $0 outlays to date on Missouri Higher Education Loan Authority contract, with options expandable to $295,652,367.

2 total filings
Β· daily

Contract Option Exercises β€” April 12, 2026

Two civilian contract option exercises totaling $1,954,256,236 in obligations occurred from April 12 to April 12, 2026, with 0 defense-related awards out of 2 total. The dominant theme is large-scale civilian agency commitments, led by Department of Commerce's $1.83B award to L3HARRIS TECHNOLOGIES, INC. and a smaller $128M Department of Education award to MISSOURI HIGHER EDUCATION LOAN AUTHORITY for student loan servicing. Highest-conviction signal is bullish for L3HARRIS TECHNOLOGIES, INC. due to its high materiality (8/10) $1.83B option exercise despite unknowns on revenue impact. Key watch item is outlay progress on MISSOURI HIGHER EDUCATION LOAN AUTHORITY's $128M award, currently at $0 with options to $295M.

2 total filings
Β· daily

Federal IT & Cybersecurity Contracts β€” April 12, 2026

The Federal IT & Cybersecurity contracts stream saw a single $1,826,088,581 obligation from April 12, 2026 to April 12, 2026, entirely civilian with 0/1 defense-related awards. Department of Commerce dominated with a $1.83B award to L3HARRIS TECHNOLOGIES, INC., despite the summary labeling it a defense contract. This represents the highest-conviction bullish signal (7/10 strength, 8/10 materiality) for L3Harris in civilian IT/cybersecurity exposure. Key risk includes unknown competition signals and pricing risk, potentially exposing the award to protests or cost overruns. Investors should watch L3Harris (LHX) for civilian revenue diversification amid sparse details on contract moat or sector alignment.

1 total filings
Β· daily

Mega Contracts Monitor ($100M+) β€” April 12, 2026

Two civilian mega contracts totaling $1,954,256,236 in obligations were awarded, with 0/2 defense-related and a split of $1.83B from Department of Commerce to L3HARRIS TECHNOLOGIES, INC. and $128M from Department of Education to MISSOURI HIGHER EDUCATION LOAN AUTHORITY. The dominant theme is civilian agency spending on unspecified services (L3Harris) and student loan servicing (Missouri). Highest-conviction signal is bullish for L3HARRIS TECHNOLOGIES, INC. on its $1.83B award, signaling strong position in Commerce procurements. Key watch item is MISSOURI HIGHER EDUCATION LOAN AUTHORITY's $0 outlays to date and potential exercises of options expanding to $295M.

2 total filings
Β· daily

High-Value Federal Grants ($5M+) β€” April 12, 2026

High-value federal grants totaling $1,954,256,236 were analyzed for the period April 12, 2026, with a 0/2 defense-related split, entirely civilian-focused. The dominant theme is Department of Commerce awarding $1.83B to L3HARRIS TECHNOLOGIES, INC., dwarfing the $128M Department of Education grant to MISSOURI HIGHER EDUCATION LOAN AUTHORITY. Highest-conviction signal is bullish for L3HARRIS TECHNOLOGIES, INC. due to its massive $1.83B obligation, signaling sustained civilian revenue stream despite the 2009 award date. Key watch item is outlay progress on MISSOURI HIGHER EDUCATION LOAN AUTHORITY's $128M contract, currently at $0 outlayed, with options to $295M.

2 total filings
Β· daily

General Federal Contracts β€” April 12, 2026

The two contracts totaling $1,954,256,236 in obligations are entirely civilian (0/2 defense-related), dominated by a massive $1.83B award to L3Harris Technologies, Inc. from the Department of Commerce. This overshadows the smaller $128M obligation to Missouri Higher Education Loan Authority from the Department of Education for student loan servicing. The highest-conviction signal is bullish for L3Harris, reflecting strong materiality (8/10) in a large-scale civilian contract labeled as defense-related. A key watch item is outlay progress on the Missouri Higher Education Loan Authority contract, currently at $0 despite $128M obligated, with options to expand to $295M.

2 total filings
Β· daily

Federal Construction & Infrastructure Contracts β€” April 11, 2026

The analyzed contracts total $173,694,639 in obligations, representing a fully civilian award with 0/1 defense-related, dominated by the Department of State's AQM Momentum office for overseas construction. BL Harbert International LLC secured this single firm fixed-price contract via full and open competition for the $173,694,639 NEC - Podgorica Montenegro project under NAICS 236220, signaling neutral investment implications with average strength 4/10 and materiality 3/10. The highest-conviction signal is neutral capability in commercial/institutional building construction amid a 7.5-year performance period to March 2027. No dominant sector trends emerge from this lone contract. Key risk is high pricing risk under firm fixed-price terms with $0 outlayed to date.

1 total filings
Β· daily

VA Healthcare & Services Contracts β€” April 11, 2026

The VA Healthcare & Services Contracts stream delivered a single $518,959,505 obligation to ORACLE HEALTH GOVERNMENT SERVICES, INC., representing a 100% civilian award with zero defense-related activity during the April 11, 2026 period. This firm fixed-price, non-competed delivery order for EHRM Operations under PSC DA01 underscores VA's commitment to multi-year IT systems support, with a bullish signal driven by the substantial $518,959,505 obligation and potential upside to $632,834,475 including options. The highest-conviction signal favors ORACLE HEALTH GOVERNMENT SERVICES, INC. in stable VA IT services, highlighting its role in electronic health record modernization. A key risk is the current $0 outlays with high pricing risk under firm fixed price terms, warranting close monitoring of outlay progress and option exercises through the 2027-04-10 end date.

1 total filings
Β· daily

New Federal Contractors β€” April 11, 2026

Three new federal contracts totaling $1,236,299,978 in obligations, with 1/3 defense-related, highlight civilian agency IT and construction spending via GSA, VA, and Department of State awards to Leidos, Inc. ($543.6M), Oracle Health Government Services, Inc. ($519.0M), and BL Harbert International LLC ($173.7M). Dominant theme is mature civilian IT delivery orders with significant backlog but zero or negative outlays to date. Highest-conviction bullish signal is Oracle's $519M VA EHRM operations contract (materiality 8/10, strength 7/10), signaling stable multi-year revenue in VA IT services. Key risk is high pricing risk on firm-fixed-price structures for Oracle and BL Harbert, compounded by unexercised options and $0 outlays across all contracts. Watch outlay progress and option exercises through 2027 end dates.

3 total filings
Β· daily

Significant Contract Modifications ($10M+) β€” April 11, 2026

Significant contract modifications totaling $1,236,299,978 from April 11, 2026, feature 1/3 defense-related obligations amid predominantly civilian IT and construction sectors. Dominant themes center on GSA and VA IT delivery orders, with Leidos ($543.6M) and Oracle Health Government Services ($519.0M) providing the highest materiality bullish signals for funded backlogs in mature multi-year contracts. BL Harbert International's $173.7M State Department construction award adds neutral exposure to overseas projects. Highest-conviction signal is Oracle's $519M VA EHRM operations delivery order (materiality 8/10, strength 7/10), signaling stable VA IT demand. Key risk: $0 outlays on Oracle and BL Harbert contracts plus Leidos' negative $-1.7M outlay flag execution delays and uncertain revenue ramps.

3 total filings
Β· daily

Contract Deobligations Alert β€” April 11, 2026

Three contract deobligations totaling $1,236,299,978 in obligations highlight funded backlogs in civilian IT services, with 1/3 defense-related (VA) and 2/3 pure civilian (GSA, State Department), dominated by large IT delivery orders to Leidos ($543.6M) and Oracle Health ($519.0M). Highest-conviction bullish signal is Oracle's $519.0M VA EHRM operations award (strength 7/10, materiality 8/10), signaling multi-year VA IT stability through 2027 despite $0 outlay. Leidos' $543.6M GSA IT contract adds mature backlog upside to $729.6M, while BL Harbert's $173.7M State Department construction remains neutral. Key risk is stalled execution with Leidos' negative $-1.7M outlay and $0 progress on Oracle/BL Harbert, vulnerable to deobligation in a CR environment. Watch outlay ramps and option exercises across all three into FY2026-2027.

3 total filings
Β· daily

Contract Option Exercises β€” April 11, 2026

Option exercises across three contracts total $1,236,299,978 in obligations, with 1/3 defense-related (VA EHRM via Oracle) and the remainder civilian (GSA IT via Leidos and State construction via BL Harbert). Dominant theme is multi-year civilian IT delivery orders from GSA and VA, signaling backlog addition for Leidos Holdings (LDOS) and Oracle (ORCL) in stable federal tech services. Highest-conviction bullish signal is Oracle's $518.96M VA EHRM award (materiality 8/10), providing ~$104M annual revenue potential through 2027 amid zero outlay to date. Leidos' $543.65M GSA IT order adds funded backlog nearing end-of-life in 2024, while BL Harbert's $173.69M State construction remains neutral with low materiality. Key risk is execution on unspent obligations ($0 outlay for Oracle and BL Harbert; negative for Leidos) and high firm-fixed-price risks on Oracle and BL Harbert contracts.

3 total filings
Β· daily

Federal IT & Cybersecurity Contracts β€” April 11, 2026

Two major civilian IT contracts totaling $1,062,605,338 in obligations highlight backlog addition for Leidos ($543.6M from GSA) and Oracle Health Government Services ($519.0M from VA), with approximately 1/2 defense-related via VA's EHRM operations. The dominant theme is stable, multi-year civilian agency IT services delivery orders under NAICS 541512, emphasizing backlog for large incumbents. Highest-conviction bullish signal is Oracle's $519M firm-fixed-price, non-competed VA award (materiality 8/10, strength 7/10), signaling entrenched positioning in VA tech. Leidos adds $544M GSA cost-plus backlog nearing end in 2024. Key risk is zero/negative outlays to date on both, with Oracle's high pricing risk under firm-fixed terms.

2 total filings
Β· daily

Mega Contracts Monitor ($100M+) β€” April 11, 2026

Three mega contracts totaling $1,236,299,978 in obligations were analyzed, with 1/3 defense-related (~$412M) and 2/3 civilian (~$824M), dominated by civilian IT services awards to Leidos ($543.6M GSA) and Oracle Health ($519M VA). The highest-conviction bullish signal is Oracle Health Government Services' $518.9M VA EHRM delivery order (strength 7/10, materiality 8/10), signaling stable multi-year backlog in VA IT amid no outlays to date. Leidos' GSA IT contract adds $543.6M funded backlog nearing end in 2024, while BL Harbert's $173.7M State construction remains neutral. Key risk is $0 outlays on Oracle and BL Harbert contracts, plus Leidos' negative $-1.7M outlay, warranting watches on spending progress and option exercises.

3 total filings